Correll CU, Skuban A, Ouyang J, Hobart M, Pfister S, McQuade RD, et al. Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial. Am J Psychiatry. 2015;172(9):870-80. DOI: 10.1176/appi.ajp.2015.14101275. PubMed PMID: 25882325.
Ogawa M, Miyamoto Y, Kawakami N. Factors associated with glycemic control and diabetes self-care among outpatients with schizophrenia and type 2 diabetes. Arch Psychiatr Nurs. 2011;25(1):63-73. DOI: 10.1016/j.apnu.2010.06.002. PubMed PMID: 21251603.
Dipasquale S, Pariante CM, Dazzan P, Aguglia E, McGuire P, Mondelli V. The dietary pattern of patients with schizophrenia: a systematic review. J Psychiatr Res. 2013;47(2):197-207. DOI: 10.1016/j.jpsychires.2012.10.005. PubMed PMID: 23153955.
Rajji TK, Mulsant BH, Davies S, Kalache SM, Tsoutsoulas C, Pollock BG, et al. Prediction of working memory performance in schizophrenia by plasma ratio of clozapine to N-desmethylclozapine. Am J Psychiatry. 2015;172(6):579-85. DOI: 10.1176/appi.ajp.2015.14050673. PubMed PMID: 25859763.
Kane JM, Schooler NR, Marcy P, Correll CU, Brunette MF, Mueser KT, et al. The RAISE early treatment program for first-episode psychosis: background, rationale, and study design. J Clin Psychiatry. 2015;76(3):240-6. DOI: 10.4088/JCP.14m09289. PubMed PMID: 25830446.